Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate - A Pilot Study

NCT01448720 is registered in ClinicalTrials.gov with Janssen-Cilag Farmaceutica Ltda. as lead sponsor.

NCT NCT01448720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate - A Pilot Study
Lead sponsor
Janssen-Cilag Farmaceutica Ltda.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
December 31, 2013
Enrollment
142 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia